Detection of tumor response to chemotherapy by 1H nuclear magnetic resonance spectroscopy: Effect of 5-fluorouracil on lactate levels in radiation-induced fibrosarcoma 1 tumors

Cancer Research

Volumn 58, Issue 5, 1998, Pages 1063-1067

  Aboagye, Eric O ^a   Bhujwalla, Zaver M ^a   Shungu, Dikoma C ^b   Glickson, Jerry D ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEUROLOGICAL INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; LACTIC ACID; TRIMETHYLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL DEATH; CELL DENSITY; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FIBROSARCOMA; GLYCOLYSIS; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; FIBROSARCOMA; FLUOROURACIL; HUMANS; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED C3H; NEOPLASMS, EXPERIMENTAL; NEOPLASMS, RADIATION-INDUCED; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0032031002     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. 31P MRS of experimental tumors. NMR Biomed., 6: 345-365, 1993.
2. Daly, P. F., and Cohen, J. S. Magnetic resonance spectroscopy of tumors and potential in vivo clinical applications: a review. Cancer Res., 49: 770-779, 1989.
3. Glickson, J. D., Wehrle, J. P., Rajan, S. S., Li, S-J., and Steen, R. G. NMR spectroscopy of tumors. In: J. W. Pettegrew (ed.), NMR in Biomedical Research, pp. 253-307. New York: Springer-Verlag, 1989.
4. Gadian, D. G. Magnetic resonance spectroscopy as a probe of tumour metabolism. Eur. J. Cancer, 27: 526-528, 1991.
5. Negendank, W. Studies of human tumors by MRS: a review. NMR Biomed., 5: 303-324, 1992.
6. 31P NMR spectroscopy: a review. Cancer Res., 49: 4075-4085, 1989.
7. 1H NMR spectroscopy. Magn. Reson. Med., 32: 277-284, 1994.
8. Bhujwalla, Z. M., Shungu, D. C., and Glickson, J. D. Effects of blood flow modifiers on tumor metabolism observed in vivo by proton magnetic resonance spectroscopic imaging. Magn. Reson. Med., 36: 204-211, 1996.
9. Bhujwalla, Z. M., and Glickson, J. D. Detection of tumor response to radiation therapy by in vivo proton MR spectroscopy. Int. J. Radiat. Oncol. Biol. Phys., 36: 635-639, 1996
10. 1H NMR spectroscopy of subcutaneous tumors in mice: preliminary studies of effects of growth, chemotherapy and blood now reduction. NMR Biomed., 5: 296-302, 1992.
11. Hayes, D. F., Henderson, I. C., and Shapiro, C. L. Treatment of metastatic breast cancer: present and future prospects. Semin. Oncol., 22: 5-19, 1995.
12. Bleiberg, H. Role of chemotherapy for advanced colorectal cancer: new opportunities. Semin. Oncol., 23: S42-S50, 1996.
13. Stupp, R., and Vokes, E. E. 5-Fluorouracil plus radiation for head and neck cancer. J. Infus. Chemother., 5: 55-60, 1995.
14. Greenhalgh, D. A., and Parish, J. H. Effect of 5-fluorouracil combination therapy on RNA processing in human colonie carcinoma cells. Br. J. Cancer, 61: 415-419, 1990.
15. Pizzorno, G., Sun, Z., and Handschumacher, R. E. Aberrant cell cycle inhibition pattern in human colon carcinoma cell lines after exposure to 5-fluorouracil. Biochem. Pharmacol., 49: 553-557, 1995.
16. Pinedo, H. M., and Peters, G. F. J. Fluorouracil: biochemistry and pharmacology. J. Clin. Oncol., 6: 1653-1664, 1988.
17. Lewin, F., Skog, S., Tribukait, B., and Ringborg, U. Cell death in relation to cell cycle in a mouse ascites tumor growing in vivo after combined treatment with cisplatin and 5-fluorouracil. Anticancer Drugs, 1: 37-44, 1990.
18. Barry, M. A., Behnke, C. A., and Eastman, A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol., 40: 2353-2362, 1990.
19. Li, S-J., Wehrle, J. P., Glickson, J. D., Kumar, N., and Braunschweiger, P. G. Tumor bioenergetics and blood flow in RIF-1 murine tumors treated with 5-fluorouracil. Magn. Reson. Med., 22: 47-56, 1991.
20. Twentyman, P. R., Brown, M. J., Gray, J. W., Franko, A. J., Scoles, M. A., and Kallman, R. F. A new mouse tumour model system (RIF-1) for comparison of end-point studies. J. Natl. Cancer Inst., 64: 595-604, 1980.
21. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119: 493-501, 1992.
22. Chalkley, H. W. Method for quantitative morphologic analysis of tissues. J. Natl. Cancer Inst., 4: 47-53, 1943.
23. Sen, S., and D'Incalci, M. Apoptosis. FEBS Lett., 307: 122-127, 1992.
24. 2H NMR spectroscopy using water as an internal intensity reference. Magn. Reson. Med., 28: 105-21, 1992.
25. 19F magnetic resonance spectroscopy studies of the metabolism of 5-fluorouracil in murine RIF-1 tumors and liver. Cancer Res., 51: 1384-1390, 1991.
26. Braunschweiger, P. G., Ting, H. L., and Schiffer, L. M. Role of corticosteroid hormones in the control of cell proliferation in residual tumor after surgical cytoreduction. Cancer Res., 43: 5801-5807, 1983.
27. Zaghloul, M. S., Dorie, M. J., and Kallman, R. F. Interleukin-1 modulatory effect on the action of chemotherapeutic drugs and localized irradiation of the lip, duodenum, and tumor. Int. J. Radial. Oncol. Biol. Phys., 26: 417-425, 1993.
28. Tozer, G., Suit, H. D., Barlai-Kovach, M., Brunengraber, H., and Biaglow, J. Energy metabolism and blood flow perfusion in a mouse mammary adenocarcinoma during growth and following X-irradiation. Radiat. Res., 109: 275-293, 1987.
29. 13C resonances. Biochim. Biophys. Acta, 805: 104-116, 1984.
30. Smith, T. A. D., Eccles, S., Ormerod, M. G., Tombs, A. J., Titley, J. C., and Leach, M. O. Phosphocholine and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumor correlates strongly with growth rate. Br. J. Cancer, 64: 821-826, 1991.
31. Walliser, S., and Redmann, K. Effect of 5-fluorouracil and thymidine on the transmembrane potential and f potential of HeLa cells. Cancer Res., 38: 3555-3559, 1978.
32. Degani, H., and Lenkinski, R. E. Ionophoric properties of angiotensin II peptide: nuclear magnetic resonance studies of the hormone-mediated transport of manganese ions across phosphatidylcholine bilayers. Biochemistry, 19: 3430-3434, 1980.
33. 31P NMR spectroscopy. Proc. Soc. Magn. Reson., 1: 68, 1995.